14 Patents
- US125401792026Compositions and Methods for Treating Cancer with Anti-ror1 Immunotherapy
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
0 cites - US124537802025Monoclonal Antibodies Specific for Fibroblast Growth Factor Receptor 4 (FGFR4) and Methods of Their Use
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
0 cites - US123919582025Compositions and Methods for Treating Cancer with Anti-cd38 Immunotherapy
The U.S.A., As Represented By The Secretary, Department Of Health And Human Services
0 cites - US120374032024Compositions and Methods for Treating Cancer with Anti-cd123 Immunotherapy
The U.S.A., As Represented By The Secretary, Department Of Health And Human Services
0 cites - US120374042024Human Monoclonal Antibodies Against Epha4 and Their Use
THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY
0 cites - US120180772024Methods of Treatments Using Antigen-binding Proteins Targeting CD56
THE U.S.A. AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
0 cites - US120124552024Human Monoclonal Antibodies Specific for FLT3 and Uses Thereof
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
0 cites - US119705282024Compositions and Methods for Treating Cancer with Anti-mesothelin Immunotherapy
The U.S.A., As Represented By The Secretary, Department Of Health And Human Services
0 cites - US119393772024Affinity Matured Cd22-specific Monoclonal Antibody and Uses Thereof
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services
0 cites - US118780522024Compositions and Methods for Treating Cancer with Anti-cd22 Immunotherapy
The U.S.A., As Represented By The Secretary, Department Of Health And Human Services
0 cites - 0 cites
- US118076822023M971 Chimeric Antigen Receptors
The United States Of America, As Represented By The Secretary, Department Of Heath And Human Services
0 cites - US117084082023Compositions and Methods for Treating Cancer with Anti-cd19 Immunotherapy
The U.S.A. As Represented By The Secretary, Department Of Health And Human Services
0 cites - US117024722023Method of Reducing Mesothelin-expressing Tumor Burden by Administration of T Cells Comprising Mesothelin-targeted Chimeric Antigen Receptors
THE U.S.A. AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
0 cites